Early diagnosis of autism spectrum disorder (ASD) is necessary to ensure patients receive early intervention services. National guidelines emphasize screening in early childhood, particularly before school entry.1 Changes introduced in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) in 2013, which redefined ASD as a spectrum and eliminated separate categories such as Asperger’s syndrome, have likely influenced diagnostic practices.2 Despite these guidelines, the American Academy of Pediatrics notes that adherence to universal screening recommendations for ASD remain low.3
To understand trends in ASD diagnoses over time, we studied 338,415 patients with a pattern of established care who received their first ASD diagnosis between 2015 and 2024. We found that the overall average age at ASD diagnosis remained stable at around 10.5 years, while the median age decreased from 7 in 2015 to 6 in 2024. When the average is higher than the median, it typically reflects a small but significant group being diagnosed much later, potentially into adulthood, which pulls the average upward.
Among male patients, diagnoses are increasingly occurring earlier, with the median age at diagnosis dropping from 7 to 5 and the average age dropping from 10.2 to 9.2 over the study period. In contrast, the median age for female patients has stayed consistent at about 8 years, while the average age at diagnosis increased from 11.7 years in 2015 to 13.1 years in 2024.
We then examined the age distribution at the time of autism diagnosis. Early detection has become more common among male patients, with 44% diagnosed before age 5 in 2024, compared to 34% of females. In contrast, nearly one in four female patients with ASD were diagnosed as adults (age 19 or older), more than double adult diagnoses among males (12%). More than half of both males and females were diagnosed after age 5 and might have benefitted from earlier diagnosis.
These findings underscore ongoing improvements in early childhood autism detection, particularly for boys, while highlighting a parallel rise in adult diagnoses among women. Persistent differences in age at diagnosis by sex suggest that symptom presentation and screening continue to differ in males and females.